
HIV prevention drug hailed as breakthrough, but who gets access? - Al Jazeera
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Sugary foods combined with antibiotic treatment can damage the gut microbiome in ways that could make people sick.

Maladaptive daydreaming, obsessional jealousy and misophonia are now topics of study as social media trends force psychiatrists to rethink their diagnostic “bible.”

The York Gospels, a 1,000-year-old manuscript, revealed ancient sheeppox virus DNA preserved in its parchment pages, stunning researchers worldwide.

The mosquito-borne disease has reached the highest numbers of infections and deaths in years, and the newly arrived El Niño may make things worse.

A Mayo Clinic researcher told Newsweek he’s “cautiously optimistic” microbiome cancer tests are nearing clinics.

A new IARC analysis links 2.3 million cancer cases worldwide to 12 infections, with H. pylori, HPV and hepatitis B leading the global burden.

It’s the start of sick season throughout the United States.

This unconventional method gained a lot of traction on social media — and it’s not totally unfounded.